Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT05398640 |
| Title | Expanded Access Program of Lifileucel (LN-144) in Patients With Unresectable or Metastatic Melanoma |
| Recruitment | No longer available |
| Gender | both |
| Phase | Expanded access |
| Variant Requirements | No |
| Sponsors | Iovance Biotherapeutics, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| HonorHealth Research and Innovation Institute | Scottsdale | Arizona | 85258 | United States | Details | |
| Orlando Health Cancer Institute | Orlando | Florida | 32806 | United States | Details | |
| University of Louisville - Brown Cancer Center | Louisville | Kentucky | 40202 | United States | Details | |
| Washington University School of Medicine - Siteman Cancer Center | Saint Louis | Missouri | 63110 | United States | Details | |
| Memorial Sloan Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
| The University of Tennessee Medical Center | Knoxville | Tennessee | 37920 | United States | Details |